This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nano and Advanced Materials Institute Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Pak Ho Lau - Innovator in Fast Drug Absorption Technology
Introduction
Pak Ho Lau is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that enhances the absorption of active ingredients in pharmaceuticals.
Latest Patents
Pak Ho Lau holds a patent for a "High loading and fast disintegration film for fast drug absorption." This invention involves a film-forming composition that includes a film-forming component and a solvent. The composition consists of 0-50 wt % of a first water-soluble polymer, 0.3-40 wt % of a second water-soluble polymer, 0-15 wt % of a plasticizer, and 50-70 wt % of an active ingredient. The polymers used have a glass transition temperature (Tg) ranging from -52°C to 216°C, with a Tg difference between the two polymers of 62-268°C. This film is designed to load a high content of active ingredients, facilitating rapid absorption.
Career Highlights
Pak Ho Lau is associated with the Nano and Advanced Materials Institute Limited, where he applies his expertise in material science to develop innovative solutions for drug delivery. His work focuses on creating advanced materials that improve the efficacy of pharmaceuticals.
Collaborations
Pak Ho Lau has collaborated with notable colleagues, including Jinjie Xu and Sau Kuen Connie Kwok, to further enhance the research and development of drug delivery technologies.
Conclusion
Pak Ho Lau's contributions to the field of fast drug absorption technology exemplify the importance of innovation in pharmaceuticals. His work continues to pave the way for advancements in drug delivery systems that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
